These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2601627)

  • 1. Anti-idiotypic antibodies in the study and treatment of experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Methods Enzymol; 1989; 178():433-48. PubMed ID: 2601627
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiidiotypic antibodies in the regulation of experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1987; 505():676-82. PubMed ID: 3500670
    [No Abstract]   [Full Text] [Related]  

  • 3. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 4. Auto-anti-idiotypic immunity and acetylcholine receptors.
    Lefvert AK
    Concepts Immunopathol; 1986; 3():285-310. PubMed ID: 3297327
    [No Abstract]   [Full Text] [Related]  

  • 5. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
    Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
    Nature; 1983 Feb 17-23; 301(5901):611-4. PubMed ID: 6402708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-idiotopic antibody on the course of experimental autoimmune myasthenia gravis.
    Agius MA; Yuen E
    Ann N Y Acad Sci; 1998 May; 841():584-6. PubMed ID: 9668301
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR; Sourojon M; Fuchs S
    J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML; Geffard M
    Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-line affinity chromatographic removal of specific antibody from rabbits with experimental myasthenia gravis as a prelude to immunotherapy.
    Hinman CL; Stevens-Truss R
    Immunopharmacol Immunotoxicol; 1998 May; 20(2):233-49. PubMed ID: 9653670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subunit specificity of the acetylcholine receptor antibodies in double seropositive myasthenia gravis.
    Zouvelou V; Michail M; Belimezi M; Zisimopoulou P
    Muscle Nerve; 2021 Apr; 63(4):E36-E37. PubMed ID: 33471417
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
    Heilbronn E
    Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
    [No Abstract]   [Full Text] [Related]  

  • 13. Future therapeutic strategies in autoimmune myasthenia gravis.
    Psaridi-Linardaki L; Mamalaki A; Tzartos SJ
    Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis.
    Lefvert AK
    J Autoimmun; 1988 Feb; 1(1):63-72. PubMed ID: 3267109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible cause of myasthenia gravis: idiotypic networks involving bacterial antigens.
    Dwyer DS; Vakil M; Bradley RJ; Oh SJ; Kearney JF
    Ann N Y Acad Sci; 1987; 505():461-71. PubMed ID: 2446558
    [No Abstract]   [Full Text] [Related]  

  • 16. Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies.
    Roberts A; Lang B; Vincent A; Newsom-Davis J
    Autoimmunity; 1992; 12(1):53-60. PubMed ID: 1617105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.
    Strijbos E; Verschuuren JJGM; Kuks JBM
    J Neuromuscul Dis; 2018; 5(2):261-264. PubMed ID: 29865092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis and treatment of myasthenia gravis.
    Levinson AI; Zweiman B; Lisak RP
    J Clin Immunol; 1987 May; 7(3):187-97. PubMed ID: 3036906
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
    Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
    Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.